Table 5 Adverse events, by year, in participants who received dihydroartemisinin-piperaquine
Adverse event | 2017 | 2018 | Total n (%) |
|---|---|---|---|
Vomiting | 8 | 3 | 11 (14.7) |
Loose stools | 4 | 6 | 10 (13.3) |
Diarrhoea | 0 | 7 | 7 (9.3) |
Dizziness | 3 | 4 | 7 (9.3) |
Nausea | 6 | 1 | 7 (9.3) |
Body aches | 5 | 1 | 6 (8.0) |
Abdominal pain | 1 | 4 | 5 (6.7) |
Headache | 2 | 3 | 5 (6.7) |
Tiredness | 2 | 3 | 5 (6.7) |
Weakness | 4 | 1 | 5 (6.7) |
Others | 2 | 5 | 7 (9.0) |
Total | 37 | 38 | 75 (100.0) |